Salvus Pharma's Acovus 100 (Acotiamide 100 mg tablets) is the definitive answer to this market gap. As a first-in-class prokinetic, it directly targets impaired gastric accommodation and delayed emptying, making it a superior therapeutic choice for gastroenterologists. Its targeted mechanism and proven efficacy position it as a premium product in the GI segment.
In a high-pressure metropolis like Mumbai, lifestyle-induced digestive disorders, particularly functional dyspepsia, are rampant. Patients often report dissatisfaction with traditional antacids and PPIs that don't address the underlying issue of poor gastric motility. This creates a significant, unmet need for an effective prokinetic agent that offers symptomatic relief and improves quality of life.
Your Franchise Opportunity in Mumbai: This is your chance to introduce a modern solution to a massive, underserved patient population. By securing the Acovus 100 PCD Pharma franchise in Mumbai, you will:
- Become a Market Leader: Capitalize on the demand for a specialized, effective treatment.
- Operate with No Competition: Benefit from our exclusive, monopoly-based rights for your territory.
- Receive Unmatched Support: Get a full suite of promotional tools and strategic guidance from Salvus Pharma, a trusted, ISO-certified company.
Quality & Trust: Our Acovus 100 tablets are manufactured in state-of-the-art, WHO-GMP certified facilities, ensuring a product that meets global quality benchmarks.
Take Action: To explore this strategic business venture in Mumbai, contact Salvus Pharma today at +91 9888902349 or email marketing@salvuspharma.in.
